Arca
Skip to content
Tools
Tools

PTGER2: Prostaglandin E2 receptor EP2 subtype

Receptor for prostaglandin E2 (PGE2).

  • Drugs that act on it: 6
  • Approved: 2
  • In phases 1 to 3: 4
  • Sponsors: 2

Who is on it, and how far along

Every drug ChEMBL records acting on PTGER2, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 6

Approved2

  • Alprostadil
  • Omidenepag isopropyl

Phase 30

    Phase 24

    • Evatanepag
    • Omidenepag
    • Simenepag isopropyl
    • Taprenepag isopropyl

    Phase 10

      Sponsors

      Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Prostanoid EP2 receptor agonist.
      AlprostadilBoxed warningApprovedPfizerSmall moleculeAgonist28
      Omidenepag isopropylApprovedOcuvex TherapSmall moleculeAgonist0
      EvatanepagPhase 2PfizerSmall moleculeAgonist0
      OmidenepagPhase 2—Small moleculeAgonist0
      Simenepag isopropylPhase 2—Small moleculeAgonist0
      Taprenepag isopropylPhase 2—Small moleculeAgonist0

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
      Comparing MOP, Prostaglandin E1, and Calcitriol to Accelerate Orthodontic Tooth MovementAlprostadilPhase 2RecruitingGhufran Dhari AwadSep 25, 2026
      Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment RecommendationsAlprostadil—RecruitingAssistance Publique - Hôpitaux de ParisJul 31, 2026
      Registry of Outcomes of Dezawa MuseCells®Alprostadil—RecruitingMuseCell Innovations Pte LTDJun 12, 2026
      A Single-Arm, Dose Escalation of an Intraurethral Alprostadil Paste for Erectile DysfunctionAlprostadilPhase 2RecruitingRyan Flannigan, MDMay 22, 2026
      Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative TherapyAlprostadil—Enrolling by invitationHealing Hope InternationalApr 9, 2026
      Intra Ovarian Muse Cell Injection for Perimenopause Symptom Relief and Ovarian Function Restoration (MUSE-OVARY)Alprostadil—Enrolling by invitationHealing Hope InternationalApr 6, 2026
      Creation of a Scale for Assessing Pain and Discomfort in Extremely Premature Infants (EDEX) Hospitalised in Neonatal Intensive Care, Inspired by the Early Infant Pain and Discomfort Scale (EDIN)Alprostadil—Not yet recruitingCentre Hospitalier Universitaire de la RéunionMar 18, 2026
      Continuous Music and Sports Training for ChildrenAlprostadilNot applicableNot yet recruitingHong Kong Baptist UniversityMar 13, 2026

      Diseases most associated with it

      Open Targets association score, 0 to 1; all associations
      Cardiovascular disorder
      0.37
      Patent ductus arteriosus
      0.37
      Neurodegenerative disease
      0.30
      Premature rupture of membranes
      0.28
      Thyroid hormone resistance, generalized, autosomal dominant
      0.27
      Fetal growth restriction
      0.26
      Pain
      0.26

      Genes and related targets

      Complexes and families that share a gene with this target
      Genes
      PTGER2

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1881, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P43116, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

      Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.